The results of COMPANION also demonstrate that CRT or CRT-D, in combination with optimal pharmacologic therapy (OPT), each respectively reduced the rate of death or hospitalization from any cause by ...

Among patients with nonischemic cardiomyopathy who require cardiac resynchronization therapy, a pacemaker may have comparable efficacy and more cost efficiency compared with a defibrillator, according ...

Pacemakers do not result in lower survival than implantable cardiac defibrillator (ICD) devices in patients undergoing cardiac resynchronization therapy (CRT) for heart failure, a large health claims ...

Barcelona, Spain, 1 September: The European cardiac resynchronization therapy (CRT) Survey is a joint initiative taken by the Heart Failure Association (HFA) and European Heart Rhythm Association ...